InvestorsHub Logo
Followers 75
Posts 1288
Boards Moderated 0
Alias Born 05/20/2012

Re: None

Monday, 03/11/2013 5:30:17 AM

Monday, March 11, 2013 5:30:17 AM

Post# of 75926
SNDY READY FOR MASSIVE EXPLOSION IN SALES DUE TO INCREASING DEMAND FOR LIFE SAVING DEVICES FOR COLLOSIAL EUROPEAN AND CANADIAN MARKETS


www.bizjournals.com

Solos Endoscopy Manufacturer to Conduct New Testing to Increase Sterilization Life for its MammoView® Breast Endoscopy Product Line
PR Newswire
BOSTON, Oct. 24, 2012
BOSTON, Oct. 24, 2012 /PRNewswire/ -- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company's manufacturer of introducers, dilators and cytology retrieval kits has retained a medical testing facility in order to verify an increase in the sterilization expiration date for the disposable instruments that are part of the MammoView® Breast Endoscopy product line. Currently, the MammoView® Breast Endoscopy disposables have a one year expiration date; the Company is now testing in order to give the products a two year expiration date.

Solos Endoscopy MammoView® Instruments are already FDA approved, however, by increasing the sterilization life to two years, the Company will be able to carry more inventory and ultimately increase sales as hospitals can be more confident in ordering larger quantities.

"Management expects that this improvement will benefit everyone, from the hospitals to the shareholders. The Company's ability to manufacture and carry more inventory will improve our margins, and give our customers greater confidence when ordering larger quantities of our disposable product line," stated Solos Endoscopy CEO, Robert Segersten.